NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
NIH R21 funding opportunity supporting exploratory and developmental research at early and conceptual project stages; clinical trial applications are not accepted. The NIH Exploratory/Developmental Research Grant Program supports novel, exploratory and developmental biomedical, behavioral, and clinical research projects that may involve considerable risk and could substantially advance their field. This R21 supports novel scientific ideas or new model systems, tools, or technologies with potential for significant impact on biomedical or biobehavioral research. Review emphasizes conceptual framework, innovation, and potential to advance knowledge; extensive background material and preliminary data are not required.
This funding opportunity does not accept applications proposing clinical trial(s). Applications must not propose clinical trials. Only New, Resubmission, and Revision application types are allowed for this NOFO. Non-domestic (non-U.S.) entities, including foreign organizations, are eligible to apply; non-domestic components of U.S. organizations are also eligible to apply, and foreign components are allowed. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Program Director/Principal Investigator may work with their organization to develop an application. Applicant organizations may submit more than one application only when each application is scientifically distinct. NIH will not accept duplicate or highly overlapping applications under review at the same time.
Applications are due by 5:00 PM local time of the applicant organization on the applicable listed application due date.
The funding opportunity expires January 8, 2028.
Errors must be corrected and the changed or corrected application must be submitted to Grants.gov on or before the application due date and time; applications submitted after the deadline are considered late.
This funding opportunity does not accept applications proposing clinical trial(s).
Applications must not propose clinical trials.
Only New, Resubmission, and Revision application types are allowed for this NOFO.
Non-domestic (non-U.S.) entities, including foreign organizations, are eligible to apply; non-domestic components of U.S. organizations are also eligible to apply, and foreign components are allowed.
Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Program Director/Principal Investigator may work with their organization to develop an application.
Applicant organizations may submit more than one application only when each application is scientifically distinct.
NIH will not accept duplicate or highly overlapping applications under review at the same time.